• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of bmcmicrBioMed Centralsearchsubmit a manuscriptregisterthis articleBMC Microbiology
BMC Microbiol. 2006; 6: 87.
Published online Oct 4, 2006. doi:  10.1186/1471-2180-6-87
PMCID: PMC1609169

New PCR systems to confirm real-time PCR detection of Mycobacterium avium subsp. paratuberculosis

Abstract

Background

Johne's disease, a serious chronic form of enteritis in ruminants, is caused by Mycobacterium avium subsp. paratuberculosis (MAP). As the organism is very slow-growing and fastidious, several PCR-based methods for detection have been developed, based mainly on the MAP-specific gene IS900. However, because this gene is similar to genes in other mycobacteria, there is a need for sensitive and reliable methods to confirm the presence of MAP. As described here, two new real-time PCR systems on the IS900 gene and one on the F57 gene were developed and carefully validated on 267 strains and 56 positive clinical faecal samples.

Results

Our confirmatory PCR systems on IS900 were found sensitive and specific, only yielding weak false positive reactions in one strain for each system. The PCR system on F57 did not elicit any false positives and was only slightly less sensitive than our primary IS900-system. DNA from both naturally infected and spiked faeces that tested positive with our primary system could be confirmed with all new systems, except one low-level infected sample that tested negative with the F57 system.

Conclusion

We recommend using the newly constructed DH3 PCR system on the F57 gene as the primary confirmatory test for PCR positives, but should it fail due to its lower sensitivity, the DH1 and DH2 PCR systems should be used.

Background

Paratuberculosis (Johne's disease) is caused by Mycobacterium avium subsp. paratuberculosis (MAP). It is a ubiquitous chronic enteric wasting disease of ruminants, though in Sweden the disease is rare or absent, thanks to successful control measures in the past. It is regarded as an exotic disease and falls under the Swedish Epizootic Act, which means that in an event of an outbreak, measures must be taken promptly to combat the disease and to trace the origin of the outbreak [1,2]. When a positive case is identified, consequences for the farmer are grave and it is usually deemed necessary to slaughter the whole herd.

In the Swedish Paratuberculosis Control Program and in most of the Swedish surveillances undertaken to monitor freedom from paratuberculosis, detection is based on culture. During the culture procedure, suspected colonies are picked and identified as MAP by PCR. Other characteristics of the colony isolate act to confirm the identification made with PCR, namely acid-fast staining (acid-fast bacilli), growth characteristics (small, slow-growing) and dependence on mycobactin. The PCR methods generally used to identify and detect MAP are based on IS900, an insertion sequence considered specific for MAP [3-6]. IS900 is a 1,451 bp segment that lacks inverted terminal repeats and does not generate direct repeats in target DNA [7]. It belongs to the same family of insertion sequences as IS901, IS902, and IS1110, described in M. avium subsp. avium, M. avium subsp. silvaticum, and M. avium subsp. avium, respectively [8-10].

PCR based on IS900 has been used for direct detection of MAP, without primary culture, from milk, faecal specimens, semen, and human intestinal tissue [11-16]. Apart from being the method of choice when speed is a priority, direct PCR is also preferred when MAP is difficult or impossible to cultivate [17].

However, as IS900-like genes have been found in other unrelated Mycobacterium species, it is evident that the PCR systems used for IS900 are not completely specific for MAP [18-20]. In a recent investigation, a nested PCR on IS900 was shown to elicit false positive reactions from several mycobacterial strains [21]. It is therefore desirable to use alternative PCR systems to confirm a positive IS900 PCR for MAP. This is useful when PCR identification cannot be confirmed by conventional culture-based methods, as is the case with direct PCR and PCR identification of growth in liquid cultures [22,23].

In the present paper, two new real-time PCR systems that target other parts of IS900 than does our standard (primary) PCR [16], and one real-time PCR targeting the F57 gene, specific for MAP [24], were developed and evaluated as confirming tests on strains and clinical samples, previously found positive with our standard IS900 PCR.

Results

Specificity

All MAP strains and isolates (Table (Table1)1) proved positive with the primary PCR system and were confirmed by all three confirmatory systems. Listed in Table Table22 are a variety of other mycobacteria, as well as a few other bacterial strains, that were tested with all four real-time PCR systems. With the primary PCR system, strain 2333 proved positive, as previously reported [20]. An isolate of Mycobacterium avium subsp. avium from a Swedish horse and a Mycobacterium kubicae-related isolate from cat gave weak positive reactions (i.e. high CT values) with the IS900 systems DH1 and DH2, respectively. All the other strains tested negative. The F57 system DH3 gave no false positive reactions.

Table 1
Strains of Mycobacterium avium subsp. paratuberculosis, tested positive with the primary and confirmatory PCR systems.
Table 2
Non-target strains, tested with the primary and confirmatory PCR systems.

Direct PCR on faecal samples

The procedure of first detecting MAP (or noting PCR inhibition) with the primary system, then confirming positives with the three other new systems, worked well with direct PCR on clinical samples. When inhibitors were still present, which only was the case with samples from the External Quality Assessment (indicated in 14 of 52 samples), a dilution of the DNA or a new preparation of the original sample would usually solve the problem and inhibition only remained in three of the samples. Our method could detect MAP in 27 of the 28 valid positive samples in the 52 samples from the External Quality Assessment. When a sample produced a positive signal with the primary system, the same result was obtained with the confirmatory systems. However, as shown in Table Table3,3, for 12 of 56 positive samples, re-runs with additional replicates had to be performed on F57 in order to pick up the dispersed DNA, and for one culture-negative clinical sample with weak IS900 PCR signals, DH3 failed to confirm the presence of MAP.

Table 3
Confirmation of clinical samples of bovine faeces, positive for MAP with the primary PCR.

MAP could be detected in the spiked faeces using the primary system at a spiking level of 104 organisms/g and readily confirmed at the same concentration by all three confirmatory systems without the need for re-runs.

Sensitivity on pure DNA

The IS900 systems MP, DH1, DH2 and the F57 system DH3 yielded positive signals from DNA suspensions with the concentrations 0.1, 0.1, 0.3 and 1 MAP genomes/μl respectively.

Discussion

Real-time PCR is a sensitive method for detection that eliminates the need to open the tubes when analysing the product, a stage in other PCR techniques that often constitutes a risk of cross-contamination. In particular, the sensitive method nested PCR involves a great risk of contaminating other samples when the product from its first reaction is being transferred to the second. Real-time PCR minimises the risk of false positive results due to amplicon contamination.

Another advantage of real-time PCR is that the use of probes enhances the specificity of the reaction, as an additional match with the target DNA will be required for a positive signal. There is, however, still a risk for false positive results due to cross-reactions and positive results need to be confirmed.

To confirm PCR positives for MAP, one of the most extensively used methods is sequencing of a part of IS900 [25-27]. However, with current generally available technology, sequencing may not be the most practical method. To obtain a successful sequencing reaction, a relatively large amount of pure amplicon is needed, which weakly infected samples might not yield. Furthermore, sequencing is a laborious and expensive method [28], not suitable for confirmation of numerous positive samples. The sensitivity of real-time PCR makes it easy to use the original template DNA in reactions targeting other sites on IS900 or on other genes. Only when the template contains minute traces of MAP DNA or is slightly PCR inhibiting, can problems arise, as discussed below.

The two systems DH1 and DH2 were selected on the basis of minimal sequential similarity to related IS elements in other mycobacteria, such as the IS900 equivalent in strain 2333 [20], and minimal self-complementarity. It appears that the sequential similarity to strain 2333 predominates among the first 450 base pairs of IS900, which is also the area in which most of the systems suggested by the Primer3 software are found. Most previously described probe-based real-time PCR systems on the IS900 gene are also located there and thus, they have little or no possibility to discriminate against 2333 [29-32]. Many potential systems could therefore be excluded, after which DH1 and DH2 were selected from the remaining oligos. In contrast to IS900, F57 has no known similarities to genes on other related organisms, which made the task of selecting suitable oligos for F57 less complicated.

It may appear simpler to change the primary system to one of the new systems, as they seem to be more specific than the MP system, but it should be noted that it is not certain that each of the other systems alone is entirely specific either. When using only one of the other systems, there is instead a risk of cross-reactions with other, unknown organisms with similarities in other parts of the MAP genome. For example, only a limited number of mycobacteria that do not grow at 37°C have been tested with F57 systems. The four systems eliminate many potential false positives by complementing each other, covering different parts of the IS900 – or, as for the DH3, a part of the F57 gene. However, the DH3 together with the primary system would probably be sufficiently specific for the routine application, where DH1 and DH2 only need to be used if DH3 fails, as discussed below.

Previously published works on systems targeting F57 [33-35] have reported specificity for MAP and application of their systems on altogether 95 strains of MAP and 188 other strains. Our system DH3, targeting F57, did not produce any false positives when applied to 112 strains of MAP and 155 other strains. It is however less sensitive than the systems on IS900, as there are 15 to 20 copies of IS900 in the MAP genome [3] – and specifically 17 copies in strain K-10 [36]. This is consistent with the results of our sensitivity tests. A suspension of 0.1 MAP genomes/μl contains about 1.7 IS900 elements/μl. Since real-time PCR has been reported capable of detecting a single copy of the target gene [37-39], the successful detection of MAP in 2 to 2.5 μl of this suspension was expected. As there is only one single copy of F57 in the MAP genome, the template volume had to contain at least 1 genome for successful detection. In fact, at such low concentrations, the probability of detection drops well below 100% if an insufficient volume is tested. Use of Poisson distribution shows a 63% theoretical probability of at least 1 genome observed in 1 μl at a concentration of 1 genome/μl. In 2.5 μl of template, the probability of the same is 92% and when duplicates are run, it increases to 99.3%. Similarly, one can show that the probability of finding at least one IS900 in duplicates of 2 μl of the above-mentioned suspension (0.1 genomes/μl) is 99.9%. In reality however, any detection system is less than optimal and an occasional target copy may be lost in the process, which is why one must expect lower probability of detection at these low concentrations. DNA extracted from clinical samples may be highly complex and impure and have a slightly inhibitory effect on the PCR reaction in weak samples, even when a positive internal control indicates that inhibition should not be a problem.

In theory, the confirmatory systems could be combined and optimized to work as one single multiplex confirmatory PCR. Nevertheless, the systems were kept separate, as competition of reagents can occur in a multiplex system, thus lowering its sensitivity [40,41].

If a clinical sample proves positive with the primary system, yet any of the three confirmatory systems shows negative, an investigation into the cause of this divergence must be undertaken. If the primary system elicited a strong signal and all laboratory errors can be excluded, the likelihood is that the result was false positive, produced by some other mycobacterial strain. In that case, it would probably be of interest to further investigate this strain! The other possibility is of course that the negative system is not sensitive to all MAP strains, in spite of our extensive testing.

However, when the positive signal is very weak, there may be several reasons why some of the confirmatory systems show negative. Because the genomes are sparse and attenuated in weak samples, a positive signal may be the outcome of low probability, thus impairing reproducibility. The confirmatory systems must then be employed again, this time using more replicates. In particular, the DH3 system on F57 will have a very low probability of detection at such concentrations. In rare cases, when even repeated analyses with additional replicates yield negative results, one will have to do without confirmation with F57 and instead take other aspects into account when judging the sample as true or false positive. In fact, it was notable that the F57 system could confirm the weakest detected level of spiked faeces (104 organisms/g) at the first attempt. This was probably because the weaker concentration (103 organisms/g) was very close to the detection level of the primary system. A few weak signals were yielded by the standard PCR, but with unacceptable high CT values. Another considered explanation for occasional failure of any of the systems DH1-3 to confirm the primary system was that they might be more sensitive to inhibition than was the primary system, which contains the internal control plasmid, especially as the confirmatory systems were developed with the use of a template volume of 2.5 μl instead of 2 μl. However, no such difference in robustness has yet been shown by the authors, and it is therefore assumed that they are equally sensitive to inhibition. Ultimately, when trying to confirm a positive test, one must be certain that a weak signal in one single system is not due to laboratory contamination.

The false reactions given by the Mycobacterium avium strain originating from horse and the Mycobacterium kubicae-related isolate from cat are most likely not a problem, as they were much weaker than would be expected when using template from a resuspended colony. A high CT value (>30 cycles) by confirmation of a normal-sized colony should alert the investigator that a cross-reaction or a contamination might have occurred. One could even argue that the cut-off CT value for PCR on colonies should be lower than for direct PCR on clinical samples, which would have made the above false positives negative. It was, however, not lowered, since that would also increase the risk of occasional dismissal of colonies that are very small or partly blended with contamination flora. In contrast, when higher CT values are expected, as when direct PCR is performed on clinical samples, the above strains are unlikely to yield positive signals. But if they still do, the remaining systems will show them to be false.

Conclusion

After validation on several mycobacterial strains and on faecal samples, our new confirmatory systems were found to be both sensitive and reliable. We recommend using the DH3 PCR on the F57 gene as the primary confirmatory test for PCR positives, but if it fails due to its lower sensitivity, then the DH1 and DH2 PCR systems can be used.

Methods

Laboratory strains, growth conditions and extraction of genomic DNA

MAP strains were cultured for 8 weeks on modified Löwenstein-Jensen medium with mycobactin (4 mg/l, Allied Monitor, Fayette, MO, USA). Other mycobacterial strains were cultured on Löwenstein-Jensen medium at 37°C for up to 6 weeks, except the strains Mycobacterium marinum (CIP 104528) and Mycobacterium cookii (ATCC 49103), that grow at 30° but not at 37°C.

Laboratory strains and their various origins are shown in Tables Tables11 and and2.2. The following MAP strains have defined RFLP subtypes: strain Telford 9.2 (RFLP type S1) from R.J. Whittington and strains 5001-1425 (RFLP type B-C12), P1850/1/97 (A-C10), 17 (Z-C18), M211 (H-C1), 5TSD (B-C17), 93/433 (B-C19), P1611-15 (B-C13), 4064 (B-C1), 1038 (B-C12), 6/922 (B-C2), 6256 (D-C12), 7954 (B-C16) 25071 (B-C13), 9602 (E-C1), 9944 (E-C1), K126 (B-C17), 6042 (D-C12), M212 (B-C2), from I. Pavlik. Isolates of MAP (n = 20) from Sweden have been RFLP typed as B-C1.

Purified MAP-DNA was obtained from ATCC 19698 (American Type Culture Collection, Rockville, MD, USA) by beadbeating with zirconia/silica beads (0.1 mm, BioSpec Products, Inc., Bartlesville, OK, USA) and phenol/chloroform extraction. However, less pure DNA for confirmation of identity with real-time PCR was obtained by centrifugation of resuspended MAP colonies, heat-killed at 99°C for 10 min.

Field isolates

Single colonies, suspected to be MAP, were isolated from faecal cultures on modified Löwenstein-Jensen medium [42] or on Herrolds Egg Yolk medium, both supplemented with mycobactin (Table (Table1).1). Other mycobacterial isolates, obtained from various sources during veterinary routine diagnostic work at the Mycobacteria Laboratory at SVA, had been isolated on Löwenstein-Jensen, Stonebrink, or Middlebrook medium (Table (Table2).2). The geographical origin as well as animal host species are also given in Table Table22 and its footnotes. Two strains (Mycobacterium marinum from guppie and one Mycobacterium species from turtle) did not grow at 37°C, but only at lower temperatures.

Direct PCR on faeces

Template DNA for direct testing with real-time PCR was extracted from bovine faeces. The protocol involved removal of solid material from 1.0 to 1.2 g faeces, lysing of the bacteria by incubation in lysisbuffer with 20 μg proteinase K and beadbeating with zirconia/silica beads (0.1 mm, BioSpec Products, Inc.). Purification of the lysate was performed with a modified QIAamp protocol (QIAamp DNA Stool Mini Kit, Qiagen). For further details, refer to previously published work [43]. Clinical samples (107 in total) were obtained from the Czech Republic, Denmark, Sweden and from the USA. The latter (52 samples) were External Quality Assessment samples (Johne's Fecal Check Test) from National Veterinary Services, Ames, IA. Spiked faeces was also tested. It was spiked with different dilutions of dispersed MAP bacteria, washed free of excessive free DNA and carefully quantified in a microscope as previously described [16] to avoid overestimation of the analytical sensitivity. The final concentrations of MAP in the spiked faeces were 102 – 107 organisms/g.

Real-time PCR based on IS900 and F57

Our primary real-time PCR system used to detect MAP in the samples was the previously described MP system [16], which includes an internal control for indication of PCR inhibition. When positive, the presence of MAP was confirmed with three newly constructed systems: two based on IS900 and one based on the F57 gene. The free on-line primer design software Primer3 [44] was used to find potential primers and probes. From these, the two systems DH1 and DH2 were selected on IS900 and DH3 on F57. Candidate sequences were compared with other known genes using the BLAST Sequence Analysis Tool to check for incidental similarities. Selected oligos are listed in Table Table44.

Table 4
Primers and probes in the primary and confirmatory real-time PCR systems.

The PCR mixture comprised 6.625 μl H2O (Sigma-Aldrich) in the case of the primary MP system and 8.625 μl H2O in the confirmatory systems, 2.0 μl glycerol (Sigma-Aldrich), 2.5 μl 10× PCR-buffer II (Applied Biosystems, Foster City, CA, USA), 5.0 μl MgCl2 (25 mmol/l, Applied Biosystems), 2.0 μl GeneAmp® dNTP with UTP (2.5 mmol/l dA, C, GTP, 5 mmol/l dUTP, Applied Biosystems), 0.75 μl forward primer (10 pmol/μl), 0.75 μl reverse primer (10 pmol/μl), 0.5 μl MAP-specific probe (10 pmol/μl), 0.5 μl mimic-specific probe (10 pmol/μl) in the case of the primary MP-system, 0.125 μl AmpliTaq Gold® (5 U/μl, Applied Biosystems) and 0.25 μl AmpErase® (Uracil N-glycosylase, 1 U/μl, Applied Biosystems). The addition of glycerol allowed freezing of the PCR mixture. In the case of the MP system, 2 μl of template DNA and 2 μl of mimic molecule pWIC9 (150 fg/μl) [16] were added to each reaction tube, except for the PCR-negative controls. In the case of the confirmatory systems, no mimic molecule but 2.5 μl of template DNA was added.

The real-time PCR reaction was performed on a Rotor-Gene 3000 (Corbett Research, Mortlake, Australia) with the following program: 50°C 2 min, 95°C 10 min, repeat 95°C 15 s and 60°C 1 min, 45 times. The results were analysed with the Rotor-Gene software versions 5 and 6 and the built-in analytical tools Dynamic Tube Normalisation and Slope Correction. Real-time PCR curves of normalized fluorescence for FAM crossing a threshold value of 0.01 at less than 40 cycles were considered positive, as long as the curves had a normal and expected shape. FAM-negative curves with a positive corresponding ROX curve (i.e. a positive mimic signal) were considered as true negatives; otherwise, inhibition was suspected. DNA extracted directly from faeces was run in duplicates.

If a slightly infected clinical sample yielded positive results with all systems except the DH3 on F57, additional runs were performed; first with five replicates, then if still negative, with 15 replicates.

Sensitivity test on pure DNA

The concentration of purified MAP-DNA was determined with NanoDrop (Wilmington, DE, USA) and low, specific concentrations were obtained by serial dilution. At the lowest concentrations (less than 100 genomes per μl) the DNA was diluted in half-multiples of ten (100.5) for better resolution of the sensitivity measurement. Real-time PCR was run in duplicates on DNA suspension ranging from 10-1.5 (~0.03) to 103 MAP genomes per μl with all four PCR systems described in Table Table44.

Authors' contributions

DH participated in the design of the study, designed the PCR systems, carried out the laboratory work and drafted the manuscript. GB conceived of the study, participated in its design and coordination and helped to draft the manuscript. All authors read and approved the final manuscript.

Acknowledgements

We wish to thank Berit Juvall and Maria Söderlind for culture of mycobacterial strains and Stina Englund for valuable discussion and for providing her mycobacterial DNA collection. We are also grateful to Ivo Pavlik, Richard Whittington, Sigrun Nilsen, Steen Giese and Norma Arrigoni for providing mycobacterial strains or DNA. This study was supported by grants from the Swedish Farmers' Foundation for Agricultural Research.

References

  • Viske D, Larsson B, Engvall A, Bölske G. Paratuberculosis in Sweden. In: Chiodini RJ, Hines II ME and Collins MT, editor. Fifth International Colloquium on Paratuberculsis; Madison, Wisconsin, USA. Rehoboth, MA, USA: International Association for Paratuberculosis; 1996. pp. 143–146.
  • Sternberg S, Holmström A, Viske D, Robertsson J, Bölske G, Larsson B. Control programme for paratuberculosis in Swedish beef herds. In: Juste RA, Geijo MV and Garrido JM, editor. Seventh International Colloquium on Paratuberculosis; Bilbao, Spain. Madison, WI, USA: International Association for Paratuberculosis; 2002. pp. 438–440.
  • Moss MT, Green EP, Tizard ML, Malik ZP, Hermon-Taylor J. Specific detection of Mycobacterium paratuberculosis by DNA hybridisation with a fragment of the insertion element IS900. Gut. 1991;32:395–398. [PMC free article] [PubMed]
  • Vary PH, Andersen PR, Green E, Herman-Taylor J, McFadden JJ. Use of highly specific DNA probes and the polymerase chain reaction to detect Mycobacterium paratuberculosis in Johne's disease. J Clin Microbiol. 1990;28:933–937. [PMC free article] [PubMed]
  • Millar DS, Withey SJ, Tizard MLV, Ford JG, Hermon-Taylor J. Solid-phase hybridization capture of low-abundance target DNA sequences: application to the polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycobacterium avium subsp. silvaticum. Anal Biochem. 1995;226:325–330. doi: 10.1006/abio.1995.1232. [PubMed] [Cross Ref]
  • Englund S, Ballagi-Pordany A, Bölske G, Johansson KE. Single PCR and nested PCR with a mimic molecule for detection of Mycobacterium avium subsp. paratuberculosis. Diagn Microbiol Infect Dis. 1999;33:163–171. doi: 10.1016/S0732-8893(98)00098-4. [PubMed] [Cross Ref]
  • Green EP, Tizard MLV, Moss MT, Thompson J, Winterbourne DJ, McFadden JJ, Hermon-Taylor J. Sequence and characteristics of IS900, an insertion element identified in human Crohn's disease isolate of Mycobacterium paratuberculosis. Nucleic Acids Res. 1989;17:9063–9073. [PMC free article] [PubMed]
  • Moss MT, Malik ZP, Tizard ML, Green EP, Sanderson JD, Hermon-Taylor J. IS902, an insertion element of the chronic-enteritis-causing Mycobacterium avium subsp. silvaticum. J Gen Microbiol. 1992;138:139–145. [PubMed]
  • Kunze ZM, Wall S, Appelberg R, Silva MT, Portaels F, McFadden JJ. IS901, a new member of a widespread class of atypical insertion sequences, is associated with pathogenicity in Mycobacterium avium. Mol Microbiol. 1991;5:2265–2272. [PubMed]
  • Hernandez Perez M, Fomukong NG, Hellyer T, Brown IN, Dale JW. Characterization of IS1110, a highly mobile genetic element from Mycobacterium avium. Mol Microbiol. 1994;12:717–724. [PubMed]
  • Sanderson JD, Moss MT, Tizard MLV, Hermon-Taylor J. Mycobacterium paratuberculosis DNA in Crohn's disease tissue. Gut. 1992;33:890–896. [PMC free article] [PubMed]
  • Millar D, Ford J, Sanderson J, Withey S, Tizard M, Doran T, Hermon-Taylor J. IS900 to detect Mycobacterium paratuberculosis in retail supplies of whole pasteurized cow's milk in England and Wales. Appl Environ Microbiol. 1996;62:3446–3452. [PMC free article] [PubMed]
  • Khare S, Ficht TA, Santos RL, Romano J, Ficht AR, Zhang S, Grant IR, Libal M, Hunter D, Adams LG. Rapid and sensitive detection of Mycobacterium avium subsp. paratuberculosis in bovine milk and feces by a combination of immunomagnetic bead separation-conventional PCR and real-time PCR. J Clin Microbiol. 2004;42:1075–1081. doi: 10.1128/JCM.42.3.1075-1081.2004. [PMC free article] [PubMed] [Cross Ref]
  • Halldorsdottir S, Englund S, Nilsen SF, Olsaker I. Detection of Mycobacterium avium subsp. paratuberculosis by buoyant density centrifugation, sequence capture PCR and dot blot hybridisation. Vet Microbiol. 2002;87:327–340. doi: 10.1016/S0378-1135(02)00082-2. [PubMed] [Cross Ref]
  • Fang Y, Wu WH, Pepper JL, Larsen JL, Marras SA, Nelson EA, Epperson WB, Christopher-Hennings J. Comparison of real-time, quantitative PCR with molecular beacons to nested PCR and culture methods for detection of Mycobacterium avium subsp. paratuberculosis in bovine fecal samples. J Clin Microbiol. 2002;40:287–291. doi: 10.1128/JCM.40.1.287-291.2002. [PMC free article] [PubMed] [Cross Ref]
  • Herthnek D, Englund S, Willemsen PT, Bölske G. Sensitive detection of Mycobacterium avium subsp. paratuberculosis in bovine semen by real-time PCR. J Appl Microbiol. 2006;100:1095–1102. doi: 10.1111/j.1365-2672.2006.02924.x. [PubMed] [Cross Ref]
  • Hermon-Taylor J, Bull TJ, Sheridan JM, Cheng J, Stellakis ML, Sumar N. Causation of Crohn's disease by Mycobacterium avium subspecies paratuberculosis. Can J Gastroenterol. 2000;14:521–539. [PubMed]
  • Taddei R, Barbeiri I, Pacciarini ML, Losini I, Cammi G, Belletti GL, Arrigoni N. An IS900-like sequence in Mycobacterium porcinum strains isolated from bovine bulk milk: implications for diagnosis. In: Manning EJB and Nielsen SS, editor. Eighth International Colloquium on Paratuberculosis; Copenhagen. Madison, WI, USA: International Association for Paratuberculosis; 2005. pp. 431–437.
  • Cousins DV, Whittington R, Marsh I, Masters A, Evans RJ, Kluver P. Mycobacteria distinct from Mycobacterium avium subsp. paratuberculosis isolated from the faeces of ruminants possess IS900-like sequences detectable by IS900 polymerase chain reaction: implications for diagnosis. Mol Cell Probes. 1999;13:431–442. doi: 10.1006/mcpr.1999.0275. [PubMed] [Cross Ref]
  • Englund S, Bölske G, Johansson KE. An IS900-like sequence found in a Mycobacterium sp. other than Mycobacterium avium subsp. paratuberculosis. FEMS Microbiol Lett. 2002;209:267–271. doi: 10.1111/j.1574-6968.2002.tb11142.x. [PubMed] [Cross Ref]
  • Tasara T, Hoelzle LE, Stephan R. Development and evaluation of a Mycobacterium avium subspecies paratuberculosis (MAP) specific multiplex PCR assay. Int J Food Microbiol. 2005;104:279–287. doi: 10.1016/j.ijfoodmicro.2005.03.009. [PubMed] [Cross Ref]
  • Moss MT, Sanderson JD, Tizard MLV, Hermon-Taylor J, El-Zaatari FAK, Markesich DC, Graham DY. Polymerase chain reaction detection of Mycobacterium paratuberculosis and Mycibacterium avium subsp silvaticum in long term cultures from Crohn's disease and control tissues. Gut. 1992;33:1209–1213. [PMC free article] [PubMed]
  • Whittington RJ, Marsh I, Turner MJ, McAllister S, Choy E, Eamens GJ, Marshall DJ, Ottaway S. Rapid detection of Mycobacterium paratuberculosis in clinical samples from ruminants and in spiked environmental samples by modified BACTEC 12B radiometric culture and direct confirmation by IS900 PCR. J Clin Microbiol. 1998;36:701–707. [PMC free article] [PubMed]
  • Poupart P, Coene M, van Heuverswyn H, Cocito C. Preparation of specific RNA probe for detection of Mycobacterium paratuberculosis and diagnosis of Johne's disease. J Clin Microbiol. 1993;31:1601–1605. [PMC free article] [PubMed]
  • Bull TJ, McMinn EJ, Sidi-Boumedine K, Skull A, Durkin D, Neild P, Rhodes G, Pickup R, Hermon-Taylor J. Detection and verification of Mycobacterium avium subsp. paratuberculosis in fresh ileocolonic mucosal biopsy specimens from individuals with and without Crohn's disease. J Clin Microbiol. 2003;41:2915–2923. doi: 10.1128/JCM.41.7.2915-2923.2003. [PMC free article] [PubMed] [Cross Ref]
  • Bogli-Stuber K, Kohler C, Seitert G, Glanemann B, Antognoli MC, Salman MD, Wittenbrink MM, Wittwer M, Wassenaar T, Jemmi T, Bissig-Choisat B. Detection of Mycobacterium avium subspecies paratuberculosis in Swiss dairy cattle by real-time PCR and culture: a comparison of the two assays. J Appl Microbiol. 2005;99:587–597. doi: 10.1111/j.1365-2672.2005.02645.x. [PubMed] [Cross Ref]
  • Sechi LA, Scanu AM, Molicotti P, Cannas S, Mura M, Dettori G, Fadda G, Zanetti S. Detection and Isolation of Mycobacterium avium subspecies paratuberculosis from intestinal mucosal biopsies of patients with and without Crohn's disease in Sardinia. Am J Gastroenterol. 2005;100:1529–1536. doi: 10.1111/j.1572-0241.2005.41415.x. [PubMed] [Cross Ref]
  • van Belkum A, Struelens M, de Visser A, Verbrugh H, Tibayrenc M. Role of genomic typing in taxonomy, evolutionary genetics, and microbial epidemiology. Clin Microbiol Rev. 2001;14:547–560. doi: 10.1128/CMR.14.3.547-560.2001. [PMC free article] [PubMed] [Cross Ref]
  • Rodriguez-Lazaro D, D'Agostino M, Herrewegh A, Pla M, Cook N, Ikonomopoulos J. Real-time PCR-based methods for detection of Mycobacterium avium subsp. paratuberculosis in water and milk. Int J Food Microbiol. 2005;101:93–104. doi: 10.1016/j.ijfoodmicro.2004.09.005. [PubMed] [Cross Ref]
  • Ravva SV, Stanker LH. Real-time quantitative PCR detection of Mycobacterium avium subsp. paratuberculosis and differentiation from other mycobacteria using SYBR Green and TaqMan assays. J Microbiol Methods. 2005;63:305–317. doi: 10.1016/j.mimet.2005.04.004. [PubMed] [Cross Ref]
  • O'Mahony J, Hill C. Rapid real-time PCR assay for detection and quantitation of Mycobacterium avium subsp. paratuberculosis DNA in artificially contaminated milk. Appl Environ Microbiol. 2004;70:4561–4568. doi: 10.1128/AEM.70.8.4561-4568.2004. [PMC free article] [PubMed] [Cross Ref]
  • Kim SG, Shin SJ, Jacobson RH, Miller LJ, Harpending PR, Stehman SM, Rossiter CA, Lein DA. Development and application of quantitative polymerase chain reaction assay based on the ABI 7700 system (TaqMan) for detection and quantification of Mycobacterium avium subsp. paratuberculosis. J Vet Diagn Invest. 2002;14:126–131. [PubMed]
  • Coetsier C, Vannuffel P, Blondeel N, Denef JF, Cocito C, Gala JL. Duplex PCR for differential identification of Mycobacterium bovis, M. avium, and M. avium subsp. paratuberculosis in formalin-fixed paraffin-embedded tissues from cattle. J Clin Microbiol. 2000;38:3048–3054. [PMC free article] [PubMed]
  • Vansnick E, De Rijk P, Vercammen F, Geysen D, Rigouts L, Portaels F. Newly developed primers for the detection of Mycobacterium avium subspecies paratuberculosis. Vet Microbiol. 2004;100:197–204. doi: 10.1016/j.vetmic.2004.02.006. [PubMed] [Cross Ref]
  • Tasara T, Stephan R. Development of an F57 sequence-based real-time PCR assay for detection of Mycobacterium avium subsp. paratuberculosis in milk. Appl Environ Microbiol. 2005;71:5957–5968. doi: 10.1128/AEM.71.10.5957-5968.2005. [PMC free article] [PubMed] [Cross Ref]
  • Li L, Bannantine JP, Zhang Q, Amonsin A, May BJ, Alt D, Banerji N, Kanjilal S, Kapur V. The complete genome sequence of Mycobacterium avium subspecies paratuberculosis. Proc Natl Acad Sci USA. 2005;102:12344–12349. doi: 10.1073/pnas.0505662102. [PMC free article] [PubMed] [Cross Ref]
  • Patel S, Zuckerman M, Smith M. Real-time quantitative PCR of Epstein-Barr virus BZLF1 DNA using the LightCycler. J Virol Methods. 2003;109:227–233. doi: 10.1016/S0166-0934(03)00076-4. [PubMed] [Cross Ref]
  • Dhar AK, Roux MM, Klimpel KR. Quantitative assay for measuring the Taura syndrome virus and yellow head virus load in shrimp by real-time RT-PCR using SYBR Green chemistry. J Virol Methods. 2002;104:69–82. doi: 10.1016/S0166-0934(02)00042-3. [PubMed] [Cross Ref]
  • Palmer S, Wiegand AP, Maldarelli F, Bazmi H, Mican JM, Polis M, Dewar RL, Planta A, Liu S, Metcalf JA, Mellors JW, Coffin JM. New real-time reverse transcriptase-initiated PCR assay with single-copy sensitivity for human immunodeficiency virus type 1 RNA in plasma. J Clin Microbiol. 2003;41:4531–4536. doi: 10.1128/JCM.41.10.4531-4536.2003. [PMC free article] [PubMed] [Cross Ref]
  • Rosenstraus M, Wang Z, Chang SY, DeBonville D, Spadoro JP. An internal control for routine diagnostic PCR: design, properties, and effect on clinical performance. J Clin Microbiol. 1998;36:191–197. [PMC free article] [PubMed]
  • Walker GT, Nadeau JG, Spears PA, Schram JL, Nycz CM, Shank DD. Multiplex strand displacement amplification (SDA) and detection of DNA sequences from Mycobacterium tuberculosis and other mycobacteria. Nucleic Acids Res. 1994;22:2670–2677. [PMC free article] [PubMed]
  • Jørgensen JB. An improved medium for culture of Mycobacterium paratuberculosis from bovine faeces. Acta Vet Scand. 1982;23:352–335. [PubMed]
  • Herthnek D. Detection and Confirmation of Mycobacterium avium subsp. paratuberculosis in Clinical Samples. PhLic Thesis; Swedish University of Agricultural Sciences, Department of Biomedical Sciences and Veterinary Public Health. 2006.
  • Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000;132:365–386. [PubMed]

Articles from BMC Microbiology are provided here courtesy of BioMed Central
PubReader format: click here to try

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...